| Nov 11 |
Vericel Stock Sees RS Rating Shoot Higher
|
| Nov 11 |
What Makes Exelixis (EXEL) a Strong Momentum Stock: Buy Now?
|
| Nov 7 |
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in November
|
| Nov 5 |
Here is Why Growth Investors Should Buy Exelixis (EXEL) Now
|
| Nov 5 |
Earnings Estimates Rising for Exelixis (EXEL): Will It Gain?
|
| Nov 4 |
Exelixis (EXEL) Reliance on International Sales: What Investors Need to Know
|
| Nov 3 |
3 Magnificent Stocks Under $100 to Buy in November
|
| Nov 3 |
Reddit, Roblox And Garmin Are Among Top 10 Large Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
|
| Nov 1 |
Exelixis, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next
|
| Oct 31 |
Exelixis: Cabometyx Drives Revenue While Zanzalintinib Emerges As Future Growth Engine
|
